These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34187598)

  • 21. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.
    Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y
    J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL.
    He J; Xiao B; Li X; He Y; Li L; Sun Z
    Biomed Res Int; 2019; 2019():2732057. PubMed ID: 31976317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness.
    Chen C; Yu H; Han F; Lai X; Ye K; Lei S; Mai M; Lai M; Zhang H
    Mol Cancer; 2022 Feb; 21(1):46. PubMed ID: 35148775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
    Ding W; Tan H; Zhao C; Li X; Li Z; Jiang C; Zhang Y; Wang L
    Tumour Biol; 2016 May; 37(5):6255-60. PubMed ID: 26615424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
    Hu B; Yang XB; Yang X; Sang XT
    Aging (Albany NY); 2020 Dec; 13(2):2626-2639. PubMed ID: 33318318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition.
    Zhao Y; Liu XL; Huang JH; Yin AJ; Zhang H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5292-5302. PubMed ID: 32495862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.
    Sui CJ; Xu F; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    Am J Cancer Res; 2016; 6(12):2787-2798. PubMed ID: 28042500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
    Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
    Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircRNA circPTK2 Might Suppress Cancer Cell Invasion and Migration of Glioblastoma by Inhibiting miR-23a Maturation.
    Chen W; Wang N; Lian M
    Neuropsychiatr Dis Treat; 2021; 17():2767-2774. PubMed ID: 34456566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY; Hu M; Zhao L; Guo WS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
    Tao J; Wu D; Li P; Xu B; Lu Q; Zhang W
    Mol Med Rep; 2012 Jan; 5(1):167-72. PubMed ID: 21935572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. lncRNA GABPB1 intronic transcript 1 upregulates pigment epithelium-derived factor via miR-93 to suppress cell proliferation in hepatocellular carcinoma.
    Li B; Wei Y; Ge Q; Duan Y; Guo L
    Oncol Lett; 2021 Apr; 21(4):260. PubMed ID: 33664823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 40. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
    Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
    Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.